(Q43077067)

13 November 2017

title

Is polycystic ovary syndrome an exception for reproductive aging? (English)

1 reference

polycystic ovary syndrome

13 November 2017

main subject

1 reference

1 reference

3

1 reference

13 November 2017

Fahimeh Ramezani Tehrani

series ordinal

1

object named as

Fahimeh Ramezani Tehrani

1 reference

13 November 2017

4

Fereidoun Azizi

1 reference

13 November 2017

Masoud Solaymani-Dodaran

series ordinal

2

object named as

Masoud Solaymani-Dodaran

1 reference

13 November 2017

language of work or name

English

0 references

publication date

30 April 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

25

1 reference

13 November 2017

issue

7

1 reference

13 November 2017

page(s)

1775-1781

1 reference

Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Anti-Müllerian hormone and ovarian dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Antimüllerian hormone serum levels: a putative marker for ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Regulation of ovarian function: the role of anti-Müllerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Early follicular antimüllerian hormone as an indicator of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Factors associated with age at natural menopause in a multiethnic sample of midlife women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Testing ovarian reserve to predict age at menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Anti-Müllerian hormone: a new marker for ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ088

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEQ088

1 reference

13 November 2017

1 reference